Metabolic alterations associated with sacubitril/valsartan treatment: a systematic review and meta-analysis

The study protocol was registered in the International Prospective Register of Systematic Reviews (PROSPERO) (CRD420251057875).

Authors

Institutions

Publication Details

Journal
BMC Cardiovascular Disorders
Published
2026-02-09
DOI
https://doi.org/10.1186/s12872-026-05590-6
Primary Topic
Heart Failure Treatment and Management
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Metabolic alterations associated with sacubitril/valsartan treatment: a systematic review and meta-analysis

Parastesh Rezvanian, Negar Ostadsharif, Ali Reza Rahmani, Mohammad Fakhrolmobasheri et al.
BMC Cardiovascular Disorders
Heart Failure Treatment and Management
article

Metabolic alterations associated with sacubitril/valsartan treatment: a systematic review and meta-analysis

Parastesh Rezvanian, Negar Ostadsharif, Ali Reza Rahmani, Mohammad Fakhrolmobasheri, Farzad Adelparvar, Amir Parsa Abhari, Fouad Meraji Far
article en

Abstract

The study protocol was registered in the International Prospective Register of Systematic Reviews (PROSPERO) (CRD420251057875).

BMC Cardiovascular DisordersVol. 26(1)
Isfahan University of Medical Sciences (IR), Stony Brook University (US)
Partnerships for the goals
Openalex Percentile: Top 63%
Heart Failure Treatment and Management
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.